China NMPA Product Recall - Neurological monitoring endotracheal intubation
China NMPA product recall for Neurological monitoring endotracheal intubation by Medtronic (Shanghai) Management Co., Ltd. published January 18, 2022. Recall level: Level 2. On January 18, 2022, Medtronic (Shanghai) Management Co., Ltd. initiated a voluntary Class II recall
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Neurological monitoring endotracheal intubation by Medtronic (Shanghai) Management Co., Ltd. published January 18, 2022. Recall level: Level 2. On January 18, 2022, Medtronic (Shanghai) Management Co., Ltd. initiated a voluntary Class II recall
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox